Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NEO | BMY | AMGN | GILD | VRTX |
| Company | Neogenomics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 13.61 | 48.45 | 266.83 | 67.80 | 396.88 |
| High | 13.93 | 48.60 | 267.51 | 67.89 | 398.49 |
| Low | 13.44 | 48.24 | 263.81 | 67.18 | 392.81 |
| Last | 13.85 | 48.26 | 265.64 | 67.31 | 394.17 |
| Change | +0.10 | -0.25 | +0.13 | -0.44 | -3.19 |
| % Change | +0.73% | -0.52% | +0.05% | -0.65% | -0.80% |
| Volume | 632,800 | 11,931,111 | 2,017,500 | 4,974,900 | 695,300 |
| 20-Day Average Volume | 675,660 | 11,536,980 | 2,269,115 | 6,427,060 | 900,790 |
| Previous Close | 13.75 | 48.51 | 265.51 | 67.75 | 397.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.86 | 51.36 | 273.86 | 70.93 | 408.62 |
| 20-Day Raw Stochastic | 16.43% | 2.20% | 7.39% | 1.83% | 4.75% |
| 20-Day Relative Strength | 39.97% | 36.07% | 38.83% | 30.61% | 37.13% |
| Weighted Alpha | -19.82 | -30.24 | +5.85 | -23.45 | +15.90 |
| Today's Opinion | 88% Sell | 56% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 88% Sell | 56% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 48% Sell | 8% Sell | 8% Sell | 72% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.00% since 04/09/24 | -6.47% since 04/09/24 | -1.75% since 04/09/24 | -3.76% since 04/09/24 | -2.55% since 04/09/24 |
| Low | 13.44 on 04/16/24 | 48.12 on 04/15/24 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 392.81 on 04/16/24 |
| High | 14.90 on 04/10/24 | 51.28 on 04/10/24 | 273.00 on 04/11/24 | 69.76 on 04/10/24 | 404.69 on 04/11/24 |
| 1-Month | |||||
| %Chg | -5.72% since 03/15/24 | -7.80% since 03/15/24 | -1.20% since 03/15/24 | -8.66% since 03/15/24 | -3.32% since 03/15/24 |
| Low | 13.44 on 04/16/24 | 48.12 on 04/15/24 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 392.81 on 04/16/24 |
| High | 15.91 on 03/28/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -10.59% since 01/16/24 | -3.48% since 01/16/24 | -12.47% since 01/16/24 | -21.72% since 01/16/24 | -9.90% since 01/16/24 |
| Low | 13.44 on 04/16/24 | 47.58 on 02/06/24 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 392.81 on 04/16/24 |
| High | 17.49 on 02/23/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +9.49% since 10/16/23 | -15.59% since 10/16/23 | -7.40% since 10/16/23 | -15.01% since 10/16/23 | +5.39% since 10/16/23 |
| Low | 12.51 on 10/17/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 67.18 on 04/16/24 | 341.90 on 11/16/23 |
| High | 21.22 on 12/22/23 | 57.65 on 10/17/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,755,408 | 98,318,080 | 142,291,856 | 84,353,968 | 102,701,272 |
| Shares Outstanding, K | 127,666 | 2,026,759 | 535,919 | 1,245,077 | 258,459 |
| Annual Sales | 591,640,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -87,970,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 155,550,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -14,330,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.10 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.03 on 02/20/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 04/30/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.44 | 14.33 | 10.13 | 29.51 |